- Home
- SLGL vs CHPT Comparison
SLGL vs CHPT Comparison
Compare SLGL & CHPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLGL | CHPT |
|---|---|---|
| Founded | 1997 | 2007 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.7M | 155.2M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | SLGL | CHPT |
|---|---|---|
| Price | $60.00 | $6.56 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 12 |
| Target Price | ★ $110.00 | $12.68 |
| AVG Volume (30 Days) | 23.5K | ★ 559.0K |
| Earning Date | 11-20-2025 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $18,970,000.00 | ★ $403,793,000.00 |
| Revenue This Year | $122.71 | N/A |
| Revenue Next Year | N/A | $7.60 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 62.04 | N/A |
| 52 Week Low | $4.02 | $6.37 |
| 52 Week High | $75.00 | $20.60 |
Technical Indicators
Market Signals| Indicator | SLGL | CHPT |
|---|---|---|
| Relative Strength Index (RSI) | 63.45 | 36.32 |
| Support Level | $48.26 | $6.37 |
| Resistance Level | $65.17 | $7.01 |
| Average True Range (ATR) | 7.83 | 0.33 |
| MACD | -0.58 | 0.02 |
| Stochastic Oscillator | 63.05 | 11.47 |
Price Performance
Historical ComparisonAbout SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About CHPT ChargePoint Holdings Inc.
ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.